High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures

I propose that we are entering a new era for drug-discovery bioanalysis. I believe that we are already starting to have a true paradigm shift on how we perform our quantitative assays in support of lead optimization efforts.